Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral N-acetylcysteine for breast fibrocystic changes
IRCT20240213060995N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of acetylcysteine in Mastopathy (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Minimum breast cyst volume, C-reactive protein and 1 more. Started Feb 2024; status: completed.
02
Drugs
acetylcysteine
03
Conditions
Mastopathy
Beyond the preview
Go deeper on IRCT20240213060995N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240213060995N1.